Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer

The drive towards hypofractionated prostate radiotherapy is motivated by a low alpha/beta ratio for prostate cancer (1 to 3 Gy) compared to surrounding organs at risk, implying an improved therapeutic ratio with increasing dose per fraction. Early evidence from studies of ultrahypofractionated (UHF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohajer, Jonathan, Dunlop, Alex, Mitchell, Adam, Goodwin, Edmund, Nill, Simeon, Oelfke, Uwe, Tree, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674276/
https://www.ncbi.nlm.nih.gov/pubmed/33241129
http://dx.doi.org/10.1016/j.ctro.2020.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674276/
https://www.ncbi.nlm.nih.gov/pubmed/33241129
http://dx.doi.org/10.1016/j.ctro.2020.10.005

Ejemplares similares